BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24993441)

  • 21. Epigallocatechin-3-gallate Sensitizes Human 786-O Renal Cell Carcinoma Cells to TRAIL-Induced Apoptosis.
    Wei R; Zhu G; Jia N; Yang W
    Cell Biochem Biophys; 2015 May; 72(1):157-64. PubMed ID: 25539708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osthole enhances TRAIL-mediated apoptosis through downregulation of c-FLIP expression in renal carcinoma Caki cells.
    Min KJ; Han MA; Kim S; Park JW; Kwon TK
    Oncol Rep; 2017 Apr; 37(4):2348-2354. PubMed ID: 28350076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin-Dependent Kinase Inhibitor BMI-1026 Induces Apoptosis by Downregulating Mcl-1 (L) and c-FLIP (L) and Inactivating p-Akt in Human Renal Carcinoma Cells.
    Kim DE; Lee J; Park JW; Kang H; Nam YR; Kwon TK; Kim KS; Kim S
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).
    Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
    Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
    Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation.
    Verbrugge I; Maas C; Heijkoop M; Verheij M; Borst J
    Cell Death Differ; 2010 Mar; 17(3):551-61. PubMed ID: 19798106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner.
    Park EJ; Min KJ; Choi KS; Kwon TK
    Exp Cell Res; 2014 Apr; 323(1):144-154. PubMed ID: 24462458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
    Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK
    J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volasertib Enhances Sensitivity to TRAIL in Renal Carcinoma Caki Cells through Downregulation of c-FLIP Expression.
    Jeon MY; Min KJ; Woo SM; Seo SU; Kim S; Park JW; Kwon TK
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.
    Jang JH; Park JS; Lee TJ; Kwon TK
    Cancer Lett; 2010 Jan; 287(2):224-30. PubMed ID: 19632032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P; Song JH; Song DK; Zhang J; Hao C
    Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression.
    Min KJ; Um HJ; Seo SU; Woo SM; Kim S; Park JW; Lee HS; Kim SH; Choi YH; Lee TJ; Kwon TK
    Drug Dev Res; 2018 Feb; 79(1):3-10. PubMed ID: 29044596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel cyclin-dependent kinase inhibitor down-regulates tumor necrosis factor-alpha (TNF-alpha)-induced expression of cell adhesion molecules by inhibition of NF-kappaB activation in human pulmonary epithelial cells.
    Oh JH; Park EJ; Park JW; Lee J; Lee SH; Kwon TK
    Int Immunopharmacol; 2010 May; 10(5):572-9. PubMed ID: 20156602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells.
    Kim S; Lee TJ; Park JW; Kwon TK
    J Cell Biochem; 2008 Nov; 105(4):971-9. PubMed ID: 18767116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neferine-induced apoptosis is dependent on the suppression of Bcl-2 expression via downregulation of p65 in renal cancer cells.
    Kim EA; Sung EG; Song IH; Kim JY; Sung HJ; Sohn HY; Park JY; Lee TJ
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):734-742. PubMed ID: 31187116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel phospholipase C activator, m-3M3FBS, induces apoptosis in tumor cells through caspase activation, down-regulation of XIAP and intracellular calcium signaling.
    Jung EM; Lee TJ; Park JW; Bae YS; Kim SH; Choi YH; Kwon TK
    Apoptosis; 2008 Jan; 13(1):133-45. PubMed ID: 18060503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
    Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells.
    Woo HJ; Jun do Y; Lee JY; Woo MH; Yang CH; Kim YH
    J Ethnopharmacol; 2011 Jun; 135(3):626-35. PubMed ID: 21473903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells.
    Isono M; Sato A; Asano T; Okubo K; Asano T
    Anticancer Res; 2018 Oct; 38(10):5709-5716. PubMed ID: 30275191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.